INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $86,000 | -18.9% | 3,711 | -13.8% | 0.00% | -50.0% |
| Q4 2020 | $106,000 | +82.8% | 4,303 | +208.0% | 0.00% | +100.0% |
| Q3 2020 | $58,000 | -86.1% | 1,397 | -57.7% | 0.00% | -93.8% |
| Q3 2018 | $417,000 | +658.2% | 3,301 | +247.5% | 0.02% | +300.0% |
| Q4 2017 | $55,000 | -54.5% | 950 | -54.5% | 0.00% | -63.6% |
| Q3 2017 | $121,000 | -46.2% | 2,086 | +12.1% | 0.01% | -50.0% |
| Q2 2017 | $225,000 | +7.1% | 1,861 | 0.0% | 0.02% | -15.4% |
| Q1 2017 | $210,000 | +26.5% | 1,861 | +21.6% | 0.03% | +8.3% |
| Q4 2016 | $166,000 | -27.2% | 1,531 | +10.6% | 0.02% | -31.4% |
| Q3 2016 | $228,000 | +26.7% | 1,384 | +9.5% | 0.04% | +25.0% |
| Q2 2016 | $180,000 | +350.0% | 1,264 | +375.2% | 0.03% | +211.1% |
| Q4 2015 | $40,000 | – | 266 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |